Form EFFECT MBX Biosciences, Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 8, 2025 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MBX Biosciences Inc (MBX) PT Raised to $88 at Truist Securities
- ATLANT 3D Launches NANOFABRICATOR® PRO: The World's First and Only Physical Platform for AI-Driven Materials Discovery
- UP Fintech Holding Limited to Report Second Quarter 2026 Financial Results on August 26, 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share